Goldman Sachs
DERM icon

Goldman Sachs’s Journey Medical DERM Stock Holding History

Goldman Sachs’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$639K Buy
90,294
+20,905
+30% +$119K ﹤0.01% 5549
2026
Q1 		$325K Buy
69,389
+50,186
+261% +$390K ﹤0.01% 5856
2025
Q4 		$148K Sell
19,203
-14,850
-44% -$116K ﹤0.01% 6118
2025
Q3 		$242K Buy
+34,053
New +$247K ﹤0.01% 5870
2024
Q2 		– Sell
-19,965
Closed -$73.5K – 5698
2024
Q1 		$73.5K Buy
+19,965
New +$86.9K ﹤0.01% 5285
2022
Q2 		– Sell
-10,926
Closed -$53K – 6500
2022
Q1 		$53K Sell
10,926
-24,894
-69% -$124K ﹤0.01% 6261
2021
Q4 		$193K Buy
+35,820
New +$259K ﹤0.01% 5921

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Goldman Sachs's DERM Position: Q2 2026 in Review

Goldman Sachs increased its Journey Medical (DERM) stake by 30% in Q2 2026, buying an estimated $119K and bringing the position to 90,294 shares worth $639K. The position accounts for ﹤0.01% of the portfolio, ranked #5549.

Goldman Sachs first reported a position in DERM in Q4 2021 and has held it in 7 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Goldman Sachs held 90,294 shares of Journey Medical worth $639K as of Q2 2026.
  • Goldman Sachs bought 20,905 Journey Medical shares in Q2 2026, an estimated $119K.
  • Journey Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5549 holding.
  • Goldman Sachs first reported a position in Journey Medical in Q4 2021 and has held it in 7 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.